Literature DB >> 31801708

[Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway].

Meiqin Dai1, Zhuo Cai2, Nana Chen3, Jinzhou Li1, Jiayong Wen1, Lizhuan Tan1, Dan Guo1.   

Abstract

OBJECTIVE: To explore the effects of matrine on the proliferation, tumor cell stemness, β-catenin transcriptional activity and AKT/GSK3β/β-catenin signaling pathway in human hepatocellular carcinoma (HCC) HepG2 and Huh7 cells.
METHODS: The proliferation and colony formation ability of HepG2 and Huh7 cells treated with 200, 400, and 800 μg/mL matrine were evaluated with MTT assay and colony formation assay, respectively. Real-time quantitative PCR was performed to detect the mRNA expressions of CD90, epithelial cell adhesion molecule (EpCAM) and CD133, and dual-luciferase assay was used to detect the transcriptional activity of β-catenin in the treated cells. The effects of matrine on the expressions of protein kinase B (AKT), P-AKT, GSK-3β, P-GSK-3β, P-β-catenin and β-catenin proteins in the Wnt/β-catenin signaling pathway were assessed using Western blotting.
RESULTS: Matrine inhibited the proliferation of the two HCC cell lines in a time- and concentration-dependent manner. The half-inhibitory concentrations of matrine were 2369, 1565 and 909.1 μg/mL at 24, 48 and 72 h in HepG2 cells, respectively, and were 1355, 781.8, and 612.8 μg/mL in Huh7 cells, respectively. Matrine concentrationdependently suppressed colony formation of the HCC cells, producing significant inhibitory effects at 400 μg/mL P < 0.01) and 800 μg/mL P < 0.001) in HepG2 cells and at 200 μg/mL P < 0.05), 400 μg/mL P < 0.01), and 800 μg/mL P < 0.001) in Huh7 cells. Matrine at 400 and 800 μg/mL significantly inhibited the mRNA expression of CD90, EpCAM and CD133 and the transcriptional level of β-catenin in both HepG2 and Huh7 cells P < 0.05 or 0.01). Matrine at 400 and 800 μg/mL also significantly decreased the protein levels of β-catenin, P-AKT and P-GSK-3β and increased the phosphorylation level of β-catenin in both of the cell lines.
CONCLUSIONS: Matrine inhibits the proliferation, colony formation, and the expressions of tumor stem cell markers CD90, EpCAM and CD133 in both HepG2 and Huh7 cells probably by inhibiting Wnt/β-catenin signaling pathway and the transcriptional activity ofβ-catenin.

Entities:  

Keywords:  hepatocellular carcinoma; matrine; tumor cell stemness; β-catenin

Mesh:

Substances:

Year:  2019        PMID: 31801708      PMCID: PMC6867957          DOI: 10.12122/j.issn.1673-4254.2019.10.17

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  28 in total

Review 1.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

Review 2.  Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control.

Authors:  Hans Clevers; Kyle M Loh; Roel Nusse
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

3.  Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens.

Authors:  Yong-gang Cao; Shan Jing; Lei Li; Jing-quan Gao; Zhi-ying Shen; Yan Liu; Yan Xing; Ming-li Wu; Ye Wang; Chang-qing Xu; Hong-li Sun
Journal:  Phytother Res       Date:  2010-12       Impact factor: 5.878

4.  Expression of EpCAM and Wnt/ β-catenin in human colon cancer.

Authors:  F Q Zhou; Y M Qi; H Xu; Q Y Wang; X S Gao; H G Guo
Journal:  Genet Mol Res       Date:  2015-05-04

5.  Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.

Authors:  Valery Shevchenko; Nataliya Arnotskaya; Maria Korneyko; Sergry Zaytsev; Yuriy Khotimchenko; Hary Sharma; Igor Bryukhovetskiy
Journal:  Oncol Rep       Date:  2019-03-05       Impact factor: 3.906

6.  Effect and Mechanism of Sophoridine to suppress Hepatocellular carcinoma in vitro and vivo.

Authors:  BaoChun Wang; Jian Xu; HaiYang Wang; ShunWu Chang; Ning Liu
Journal:  Biomed Pharmacother       Date:  2017-09-12       Impact factor: 6.529

7.  Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.

Authors:  Taro Yamashita; Anuradha Budhu; Marshonna Forgues; Xin Wei Wang
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 8.  EpCAM and the biology of hepatic stem/progenitor cells.

Authors:  Laurent Dollé; Neil D Theise; Eva Schmelzer; Luke Boulter; Olivier Gires; Leo A van Grunsven
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

9.  Oxymatrine prevents NF-κB nuclear translocation and ameliorates acute intestinal inflammation.

Authors:  Javier Rivera Guzman; Ja Seol Koo; Jason R Goldsmith; Marcus Mühlbauer; Acharan Narula; Christian Jobin
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines.

Authors:  Margaretha A Skowron; Günter Niegisch; Gerhard Fritz; Tanja Arent; Joep G H van Roermund; Andrea Romano; Peter Albers; Wolfgang A Schulz; Michèle J Hoffmann
Journal:  J Exp Clin Cancer Res       Date:  2015-11-25
View more
  4 in total

Review 1.  Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review.

Authors:  Yingda Lin; Qiu Du; Fuming He; Ling Wu; Yuan Xu
Journal:  Drug Des Devel Ther       Date:  2022-03-01       Impact factor: 4.162

Review 2.  Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges.

Authors:  Kexin Li; Kunmin Xiao; Shijie Zhu; Yong Wang; Wei Wang
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

Review 3.  Research Advances on Matrine.

Authors:  Xiao-Ying Sun; Li-Yi Jia; Zheng Rong; Xin Zhou; Lu-Qi Cao; Ai-Hong Li; Meng Guo; Jie Jin; Yin-Di Wang; Ling Huang; Yi-Heng Li; Zhong-Jing He; Long Li; Rui-Kang Ma; Yi-Fan Lv; Ke-Ke Shao; Juan Zhang; Hui-Ling Cao
Journal:  Front Chem       Date:  2022-04-01       Impact factor: 5.545

4.  The Effects of Qinghao-Kushen and Its Active Compounds on the Biological Characteristics of Liver Cancer Cells.

Authors:  Jingmin Ji; Zhiqin Zhang; Qing Peng; Liyuan Hao; Yinglin Guo; Yu Xue; Yiwei Liu; Caige Li; Xinli Shi
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-10       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.